Computational analysis of epigenetic patterns facilitates diagnosis of unknown hereditary disorders
A new sophisticated computational model, developed by scientists at Lawson Health Research Institute, is bringing an innovative method of diagnosing rare hereditary conditions.
Genome-wide testing of DNA methylation, a mechanism of the epigenome, has been shown to facilitate the diagnosis of previously unsolved cases of neurodevelopmental or congenital abnormalities. The epigenome is any process that can change the expression of a gene without changing the gene sequence.
The latest in a series of research publications around the theme of epigenomic testing applied the new pattern recognition model to DNA samples of 965 patients with neurodevelopmental and congenital anomalies that did not have a definitive diagnosis despite extensive clinical genetic testing. Their DNA, acquired through blood samples, was examined using the new model, and dozens of new cases were resolved.
Current testing of patients who present with neurodevelopmental and congenital anomalies leaves a number of cases undiagnosed or unexplained. “Many families spend years going through repeated testing and assessments, in search of a diagnosis. This process is hard on patients and families, and is a great cost to our health care system,” explains Dr. Bekim Sadikovic, Associate Scientist at Lawson, and Head of the Molecular Genetics Division in the Department of Pathology and Laboratory Medicine, London Health Sciences Centre (LHSC).
While currently there are limited treatment options associated with many of these conditions, providing a specific diagnosis can help physicians better predict the course of the disease, allowing for better planning and support for the patient. This research highlights the value of epigenomic testing in the routine assessment of neurodevelopmental and congenital disorders.
From this research, LHSC will be the first site in the world to offer this type of genetic testing. “We are excited to make this testing accessible to local patients, and across the world. Our lab has partnered and licensed this technology to Greenwood Genetics Laboratories in the United States and Amsterdam University Medical Centre Laboratories in the European Union”, says Dr. Sadikovic. 100 per cent of revenue will be funneled back to support local testing for patients and ongoing research.
Learn more: Research leads to new molecular diagnostic tool
The Latest on: Molecular diagnostic tool
via Google News
The Latest on: Molecular diagnostic tool
- GTCR and Cole-Parmer Announce Acquisition of ZeptoMetrixon January 12, 2021 at 5:15 am
GTCR, a leading private equity firm, announced today that its Cole-Parmer ("CP") portfolio company has acquired ZeptoMetrix ...
- Myriad Genetics Forms Strategic Partnership with Illumina in Oncologyon January 12, 2021 at 1:45 am
(GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a strategic collaboration with Illumina, Inc. (NASDAQ: ILMN) for Illumina ...
- Tempus Unveils a Breakthrough in AI for Oncologists: Tempus ONEon January 12, 2021 at 1:10 am
Tempus, a leader in AI-enabled diagnostics, today unveiled a breakthrough technology for oncologists, Tempus ONE.
- Potential jurors favor use of artificial intelligence in precision medicineon January 11, 2021 at 1:14 pm
Physicians who follow artificial intelligence (AI) advice may be considered less liable for medical malpractice than is commonly thought, according to a new study of potential jury candidates in the U ...
- Cancer and genetic testing drove diagnostics industry M&A boom in 2020on January 7, 2021 at 12:02 pm
Despite the coronavirus pandemic making waves in economies around the world, the diagnostics market benefitted from increased investor interest and an upswing in mergers and acquisitions in 2020.
- Molecular Diagnostics Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2026on January 7, 2021 at 12:47 am
Selbyville, Delaware the newly Added research report at Market Study Report titled "2020-2026 Global Molecular Diagnostics Report" provides data, information, brief analysis, company profiles, ...
- Infectious Disease Diagnostics Market Research, Report, In-depth Insight, Industry Forecast to 2025 Key playerson January 6, 2021 at 6:04 am
Based on technology it covers Traditional Diagnostic Techniques and Molecular diagnostics ... of foreign antigen/organism with the assistance of assorted diagnostic tools. Communicable disease ...
- The Chinese In Vitro Diagnostics Market is Forecast to Reach USD 22.3 Billion by 2026 - ResearchAndMarkets.comon January 5, 2021 at 2:42 am
The "China In Vitro Diagnostics (IVD) Market, By Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, POCT, Coagulation) and ...
- Global Veterinary Molecular Diagnostics Markets, 2018-2030 with 2019 as the Base Year - ResearchAndMarkets.comon December 30, 2020 at 2:16 am
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. Veterinary Molecular Diagnostics Market - Scope of the ...
- Global Veterinary Molecular Diagnostics Markets, 2018-2030 with 2019 as the Base Year - ResearchAndMarkets.comon December 29, 2020 at 7:46 am
Moreover, the report sheds light on the changing competitive dynamics in the global veterinary molecular diagnostics market. These serve as valuable tools for existing market players as well as ...
via Bing News